Immunotherapy for glioblastoma well tolerated; survival gains observed – Science Daily
Science Daily |
Immunotherapy for glioblastoma well tolerated; survival gains observed
Science Daily "This is a small study, but it's one in a sequence of clinical trials we have conducted to explore the use of an immunotherapy that specifically targets a protein on glioblastoma tumors," said Duke's Kristen Batich, M.D., Ph.D., lead author of a study … News Brain Cancer Vaccine–Chemotherapy Combo … Vaccine Targeting Brain Tumors Seems Safe in Study |
